Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07415720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Study acronym: ARTI-UP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Feb 2026 to May 2026
    • Primary completion pushed from Jul 2027 to Dec 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The ARTI-UP study evaluates whether daily consumption of a supplement made from artichoke by-products, rich in hydroxycinnamic acids (HCAs), in combination with an energy-restricted Mediterranean diet (erMeDiet), can improve glycaemic control, reduce insulin resistance and contribute to weight loss in subjects with overweight or obesity. In addition, it seeks to understand the biological mechanisms involved using omic techniques and to establish predictive biomarkers that will enable progress towards personalised nutrition strategies.
Trial Details
NCT Number NCT07415720
Lead Sponsor Clinica Universidad de Navarra, Universidad de Navarra
Collaborators: University of Navarra, Hospital of Navarra
Conditions
(from sponsor)		 Diabete Type 2, Obesity & Overweight, Insulin Resistance Syndrome
Related terms Diabetes Mellitus, Type 2, Metabolic Syndrome, Obesity, Overweight
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov